Other Current Assets (Tables)

12 Months Ended

Dec. 31, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Other Current Assets

Other current assets consisted of the following at December 31:

	2023		2022
Current:
Prepaid clinical trial	$	8,763,150	$	5,656,737
Miscellaneous receivable		805,882		-
Other		281,364		351,073
Prepaid directors & officers’ insurance		157,453		173,416
Prepaid research & development		-		421,800
Total	$	10,007,849	$	6,603,026